|
Volumn 175, Issue 3, 2001, Pages 189-193
|
Attention deficit hyperactivity disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CENTRAL STIMULANT AGENT;
DEXAMPHETAMINE;
IMIPRAMINE;
METHYLPHENIDATE;
PEMOLINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CHILD;
CLINICAL TRIAL;
COMORBIDITY;
DRUG EFFICACY;
EVIDENCE BASED MEDICINE;
HUMAN;
PROGNOSIS;
PSYCHIATRIC DIAGNOSIS;
PSYCHOPHARMACOTHERAPY;
PSYCHOSOCIAL CARE;
REVIEW;
RISK ASSESSMENT;
ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY;
CHILD;
CHILD, PRESCHOOL;
COMORBIDITY;
EVIDENCE-BASED MEDICINE;
HUMANS;
MALE;
MENTAL DISORDERS;
PREVALENCE;
PROGNOSIS;
RISK ASSESSMENT;
|
EID: 0034809903
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: 10.1136/ewjm.175.3.189 Document Type: Review |
Times cited : (7)
|
References (18)
|